Showing results (1-10 of 77) with videos related to
Sort By:
Pageof 8
Annual Review of Pathology|January 24, 2025
Targeting Protein-Protein Interactions in Hematologic MalignanciesTomasz Cierpicki, Jolanta GrembeckaImmunological Reviews|December 17, 2014
Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?Tomasz Cierpicki, Jolanta GrembeckaBioorganic Chemistry|March 29, 2023
2-Aminobenzothiazoles in anticancer drug design and discoveryGuang Huang, Tomasz Cierpicki, Jolanta GrembeckaEuropean Journal of Medicinal Chemistry|August 6, 2024
Thioamides in medicinal chemistry and as small molecule therapeutic agentsGuang Huang, Tomasz Cierpicki, Jolanta GrembeckaCancer Discovery|April 3, 2019
Combined MAPK Pathway and HDAC Inhibition Breaks MelanomaDavid B Lombard, Tomasz Cierpicki, Jolanta GrembeckaFuture Medicinal Chemistry|August 23, 2016
H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor developmentDavid S Rogawski, Jolanta Grembecka, Tomasz CierpickiFuture Medicinal Chemistry|June 20, 2020
Targeting epigenetic protein-protein interactions with small-molecule inhibitorsBrian M Linhares, Jolanta Grembecka, Tomasz CierpickiJournal of Medicinal Chemistry|June 13, 2003
The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activityJolanta Grembecka, Artur Mucha, Tomasz Cierpicki, et al.European Journal of Medicinal Chemistry|September 15, 2023
Applications of oxetanes in drug discovery and medicinal chemistryGuang Huang, Devon Hucek, Tomasz Cierpicki, et al.European Journal of Medicinal Chemistry|August 27, 2005
alpha-Aminoalkylphosphonates as a tool in experimental optimisation of P1 side chain shape of potential inhibitors in S1 pocket of leucine- and neutral aminopeptidasesMarcin Drag, Jolanta Grembecka, Małgorzata Pawełczak, et al.Pageof 8